HighTower Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,314
Closed -$160K – 3828
2026
Q2
$160K Sell
15,314
-9,298
-38% -$104K ﹤0.01% 3585
2026
Q1
$293K Sell
24,612
-40,988
-62% -$419K ﹤0.01% 3201
2025
Q4
$653K Sell
65,600
-13
-0% -$124 ﹤0.01% 2427
2025
Q3
$587K Buy
65,613
+7,152
+12% +$66.2K ﹤0.01% 2483
2025
Q2
$551K Sell
58,461
-63
-0.1% -$556 ﹤0.01% 2438
2025
Q1
$634K Sell
58,524
-326
-0.6% -$3.28K ﹤0.01% 2278
2024
Q4
$560K Sell
58,850
-94,666
-62% -$958K ﹤0.01% 2389
2024
Q3
$1.73M Sell
153,516
-6,313
-4% -$67.1K ﹤0.01% 1608
2024
Q2
$1.6M Hold
159,829
– – ﹤0.01% 1571
2024
Q1
$1.84M Buy
159,829
+44,968
+39% +$382K ﹤0.01% 1475
2023
Q4
$835K Buy
114,861
+190
+0.2% +$1.5K ﹤0.01% 1939
2023
Q3
$1.04M Sell
114,671
-165
-0.1% -$1.98K ﹤0.01% 1750
2023
Q2
$1.4M Buy
114,836
+21,942
+24% +$245K ﹤0.01% 1561
2023
Q1
$1.15M Buy
+92,894
New +$1.71M ﹤0.01% 1589

Other funds holding AHCO

HighTower Advisors's AHCO Position: Q3 2026 in Review

HighTower Advisors sold out of AdaptHealth (AHCO) in Q3 2026, closing a stake of 15,314 shares — an estimated $160K sold.

HighTower Advisors first reported a position in AHCO in Q1 2023 and held it in 14 quarters. The position peaked at $1.84M in Q1 2024. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • HighTower Advisors reported no remaining AdaptHealth position as of Q3 2026 after selling out during the quarter.
  • HighTower Advisors sold 15,314 AdaptHealth shares in Q3 2026, an estimated $160K.
  • HighTower Advisors first reported a position in AdaptHealth in Q1 2023 and held it in 14 quarters.
  • HighTower Advisors's AdaptHealth position peaked at $1.84M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.